79 related articles for article (PubMed ID: 9788633)
1. Transforming growth factor beta signaling through Smad1 in human breast cancer cells.
Liu X; Yue J; Frey RS; Zhu Q; Mulder KM
Cancer Res; 1998 Oct; 58(20):4752-7. PubMed ID: 9788633
[TBL] [Abstract][Full Text] [Related]
2. Transforming growth factor-beta1 downregulation of Smad1 gene expression in rat hepatic stellate cells.
Shen H; Huang G; Hadi M; Choy P; Zhang M; Minuk GY; Chen Y; Gong Y
Am J Physiol Gastrointest Liver Physiol; 2003 Sep; 285(3):G539-46. PubMed ID: 12791600
[TBL] [Abstract][Full Text] [Related]
3. Opposing BMP and EGF signalling pathways converge on the TGF-beta family mediator Smad1.
Kretzschmar M; Doody J; Massagué J
Nature; 1997 Oct; 389(6651):618-22. PubMed ID: 9335504
[TBL] [Abstract][Full Text] [Related]
4. Over-expression of ERT(ESX/ESE-1/ELF3), an ets-related transcription factor, induces endogenous TGF-beta type II receptor expression and restores the TGF-beta signaling pathway in Hs578t human breast cancer cells.
Chang J; Lee C; Hahm KB; Yi Y; Choi SG; Kim SJ
Oncogene; 2000 Jan; 19(1):151-4. PubMed ID: 10644990
[TBL] [Abstract][Full Text] [Related]
5. Cross-talk between the Smad1 and Ras/MEK signaling pathways for TGFbeta.
Yue J; Frey RS; Mulder KM
Oncogene; 1999 Mar; 18(11):2033-7. PubMed ID: 10208426
[TBL] [Abstract][Full Text] [Related]
6. Targeting endogenous transforming growth factor beta receptor signaling in SMAD4-deficient human pancreatic carcinoma cells inhibits their invasive phenotype1.
Subramanian G; Schwarz RE; Higgins L; McEnroe G; Chakravarty S; Dugar S; Reiss M
Cancer Res; 2004 Aug; 64(15):5200-11. PubMed ID: 15289325
[TBL] [Abstract][Full Text] [Related]
7. 5-azacytidine alters TGF-beta and BMP signaling and induces maturation in articular chondrocytes.
Zuscik MJ; Baden JF; Wu Q; Sheu TJ; Schwarz EM; Drissi H; O'Keefe RJ; Puzas JE; Rosier RN
J Cell Biochem; 2004 May; 92(2):316-31. PubMed ID: 15108358
[TBL] [Abstract][Full Text] [Related]
8. TGF-beta-induced nuclear localization of Smad2 and Smad3 in Smad4 null cancer cell lines.
Fink SP; Mikkola D; Willson JK; Markowitz S
Oncogene; 2003 Mar; 22(9):1317-23. PubMed ID: 12618756
[TBL] [Abstract][Full Text] [Related]
9. Bone morphogenetic protein signaling enhances invasion and bone metastasis of breast cancer cells through Smad pathway.
Katsuno Y; Hanyu A; Kanda H; Ishikawa Y; Akiyama F; Iwase T; Ogata E; Ehata S; Miyazono K; Imamura T
Oncogene; 2008 Oct; 27(49):6322-33. PubMed ID: 18663362
[TBL] [Abstract][Full Text] [Related]
10. Transforming growth factor-beta-induced growth inhibition in a Smad4 mutant colon adenoma cell line.
Fink SP; Swinler SE; Lutterbaugh JD; Massagué J; Thiagalingam S; Kinzler KW; Vogelstein B; Willson JK; Markowitz S
Cancer Res; 2001 Jan; 61(1):256-60. PubMed ID: 11196171
[TBL] [Abstract][Full Text] [Related]
11. Role of Smad1 and Smad4 proteins in the induction of p21WAF1,Cip1 during bone morphogenetic protein-induced growth arrest in human breast cancer cells.
Pouliot F; Labrie C
J Endocrinol; 2002 Jan; 172(1):187-98. PubMed ID: 11786386
[TBL] [Abstract][Full Text] [Related]
12. Characterization of a bone morphogenetic protein-responsive Smad-binding element.
Kusanagi K; Inoue H; Ishidou Y; Mishima HK; Kawabata M; Miyazono K
Mol Biol Cell; 2000 Feb; 11(2):555-65. PubMed ID: 10679014
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of a dominant negative type II bone morphogenetic protein receptor inhibits the growth of human breast cancer cells.
Pouliot F; Blais A; Labrie C
Cancer Res; 2003 Jan; 63(2):277-81. PubMed ID: 12543773
[TBL] [Abstract][Full Text] [Related]
14. CHIP mediates degradation of Smad proteins and potentially regulates Smad-induced transcription.
Li L; Xin H; Xu X; Huang M; Zhang X; Chen Y; Zhang S; Fu XY; Chang Z
Mol Cell Biol; 2004 Jan; 24(2):856-64. PubMed ID: 14701756
[TBL] [Abstract][Full Text] [Related]
15. Phospho-Smad1 modulation by nedd4 E3 ligase in BMP/TGF-β signaling.
Kim BG; Lee JH; Yasuda J; Ryoo HM; Cho JY
J Bone Miner Res; 2011 Jul; 26(7):1411-24. PubMed ID: 21308777
[TBL] [Abstract][Full Text] [Related]
16. CD44 modulates Smad1 activation in the BMP-7 signaling pathway.
Peterson RS; Andhare RA; Rousche KT; Knudson W; Wang W; Grossfield JB; Thomas RO; Hollingsworth RE; Knudson CB
J Cell Biol; 2004 Sep; 166(7):1081-91. PubMed ID: 15452148
[TBL] [Abstract][Full Text] [Related]
17. Dendritic growth induced by BMP-7 requires Smad1 and proteasome activity.
Guo X; Lin Y; Horbinski C; Drahushuk KM; Kim IJ; Kaplan PL; Lein P; Wang T; Higgins D
J Neurobiol; 2001 Aug; 48(2):120-30. PubMed ID: 11438941
[TBL] [Abstract][Full Text] [Related]
18. Id2 and Id3 define the potency of cell proliferation and differentiation responses to transforming growth factor beta and bone morphogenetic protein.
Kowanetz M; Valcourt U; Bergström R; Heldin CH; Moustakas A
Mol Cell Biol; 2004 May; 24(10):4241-54. PubMed ID: 15121845
[TBL] [Abstract][Full Text] [Related]
19. Initiation of Smad-dependent and Smad-independent signaling via distinct BMP-receptor complexes.
Hassel S; Schmitt S; Hartung A; Roth M; Nohe A; Petersen N; Ehrlich M; Henis YI; Sebald W; Knaus P
J Bone Joint Surg Am; 2003; 85-A Suppl 3():44-51. PubMed ID: 12925609
[TBL] [Abstract][Full Text] [Related]
20. Bone morphogenetic protein signaling and growth suppression in colon cancer.
Beck SE; Jung BH; Fiorino A; Gomez J; Rosario ED; Cabrera BL; Huang SC; Chow JY; Carethers JM
Am J Physiol Gastrointest Liver Physiol; 2006 Jul; 291(1):G135-45. PubMed ID: 16769811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
